Variant report

Variant	esv3441038
Chromosome Location	chr5:16934977-16937825
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr5:16935531-16936790	H1-hESC	embryonic stem cell:	n/a	n/a
2	BRCA1	chr5:16935472-16937082	Hela-S3	cervix:	n/a	n/a
3	CEBPB	chr5:16936636-16937156	MCF-7	breast:	n/a	n/a
4	CEBPB	chr5:16937633-16938252	IMR90	lung:	n/a	chr5:16937819-16937828 chr5:16937818-16937829 chr5:16937817-16937830 chr5:16937817-16937830 chr5:16937819-16937828 chr5:16937819-16937828 chr5:16937817-16937828 chr5:16937819-16937828
5	CEBPB	chr5:16936706-16937126	A549	lung:	n/a	n/a
6	CEBPB	chr5:16936797-16937082	HepG2	liver:	n/a	n/a
7	CEBPB	chr5:16936668-16937202	MCF-7	breast:	n/a	n/a
8	CEBPB	chr5:16936732-16937144	A549	lung:	n/a	n/a
9	CEBPB	chr5:16936550-16937245	A549	lung:	n/a	n/a
10	CEBPB	chr5:16937649-16938170	A549	lung:	n/a	chr5:16937819-16937828 chr5:16937818-16937829 chr5:16937817-16937830 chr5:16937817-16937830 chr5:16937819-16937828 chr5:16937819-16937828 chr5:16937817-16937828 chr5:16937819-16937828
11	CEBPB	chr5:16935104-16937406	Hela-S3	cervix:	n/a	n/a
12	CEBPB	chr5:16937642-16938199	HepG2	liver:	n/a	chr5:16937819-16937828 chr5:16937818-16937829 chr5:16937817-16937830 chr5:16937817-16937830 chr5:16937819-16937828 chr5:16937819-16937828 chr5:16937817-16937828 chr5:16937819-16937828
13	CEBPB	chr5:16937675-16937916	H1-hESC	embryonic stem cell:	n/a	chr5:16937819-16937828 chr5:16937818-16937829 chr5:16937817-16937830 chr5:16937817-16937830 chr5:16937819-16937828 chr5:16937819-16937828 chr5:16937817-16937828 chr5:16937819-16937828
14	CEBPB	chr5:16936823-16937103	K562	blood:	n/a	n/a
15	CEBPB	chr5:16936785-16937203	ECC-1	luminal epithelium:	n/a	n/a
16	CEBPB	chr5:16936746-16937145	IMR90	lung:	n/a	n/a
17	CEBPB	chr5:16937643-16937998	K562	blood:	n/a	chr5:16937819-16937828 chr5:16937818-16937829 chr5:16937817-16937830 chr5:16937817-16937830 chr5:16937819-16937828 chr5:16937819-16937828 chr5:16937817-16937828 chr5:16937819-16937828
18	CEBPB	chr5:16936765-16937127	ECC-1	luminal epithelium:	n/a	n/a
19	CEBPB	chr5:16937633-16938257	Hela-S3	cervix:	n/a	chr5:16937819-16937828 chr5:16937818-16937829 chr5:16937817-16937830 chr5:16937817-16937830 chr5:16937819-16937828 chr5:16937819-16937828 chr5:16937817-16937828 chr5:16937819-16937828
20	CHD1	chr5:16931409-16937827	IMR90	lung:	n/a	chr5:16936283-16936293 chr5:16931647-16931657
21	CHD1	chr5:16935949-16936149	H1-hESC	embryonic stem cell:	n/a	n/a
22	CHD2	chr5:16935362-16937091	Hela-S3	cervix:	n/a	chr5:16936283-16936293
23	CHD2	chr5:16936055-16936756	H1-hESC	embryonic stem cell:	n/a	chr5:16936283-16936293
24	CHD2	chr5:16936340-16936397	K562	blood:	n/a	n/a
25	CREB1	chr5:16936026-16936794	A549	lung:	n/a	n/a
26	CTCF	chr5:16935340-16935490	HUVEC	blood vessel:	n/a	n/a
27	CTCF	chr5:16935320-16935470	AG09309	skin:	n/a	n/a
28	CTCF	chr5:16935840-16935990	WERI-Rb-1	eye:	n/a	n/a
29	CTCF	chr5:16935120-16935270	AG10803	skin:	n/a	n/a
30	CTCF	chr5:16935440-16935590	WERI-Rb-1	eye:	n/a	n/a
31	CTCF	chr5:16936120-16936270	HCPEpiC	choroid plexus:	n/a	n/a
32	CTCF	chr5:16935980-16936130	SAEC	small airway:	n/a	n/a
33	CTCF	chr5:16935380-16935530	HCFaa	heart:	n/a	n/a
34	CTCF	chr5:16935854-16936035	MCF-7	breast:	n/a	n/a
35	CTCF	chr5:16936020-16936170	AG09319	gingival:	n/a	n/a
36	CTCF	chr5:16936040-16936190	GM12874	blood:	n/a	n/a
37	CTCF	chr5:16935640-16935790	SAEC	small airway:	n/a	n/a
38	CTCF	chr5:16935960-16936110	HRE	kidney:	n/a	n/a
39	CTCF	chr5:16935924-16935957	MCF-7	breast:	n/a	n/a
40	CTCF	chr5:16935060-16935210	AG10803	skin:	n/a	n/a
41	CTCF	chr5:16934119-16935437	SK-N-SH	brain:	n/a	chr5:16934333-16934351 chr5:16934336-16934349 chr5:16934335-16934356
42	CTCF	chr5:16935080-16935230	HFF-Myc	foreskin:	n/a	n/a
43	CTCF	chr5:16935800-16935950	Hela-S3	cervix:	n/a	n/a
44	CTCF	chr5:16935916-16936008	MCF-7	breast:	n/a	n/a
45	CTCF	chr5:16935920-16936070	HBMEC	blood vessel:	n/a	n/a
46	CTCF	chr5:16935860-16936010	AG04449	skin:	n/a	n/a
47	CTCF	chr5:16936000-16936150	AG10803	skin:	n/a	n/a
48	CTCF	chr5:16933526-16935088	A549	lung:	n/a	chr5:16934333-16934351 chr5:16934336-16934349 chr5:16934335-16934356
49	CTCF	chr5:16935940-16936090	BJ	skin:	n/a	n/a
50	CTCF	chr5:16936052-16936054	MCF-7	breast:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:16935888-16935938	NHBE	bronchial:	n/a
2	chr5:16936458-16936508	HUVEC	blood vessel:	n/a
3	chr5:16936466-16936516	HEEpiC	esophagus:	n/a
4	chr5:16935888-16935938	NHBE	bronchial:	n/a
5	chr5:16936458-16936508	HUVEC	blood vessel:	n/a
6	chr5:16936466-16936516	HEEpiC	esophagus:	n/a
7	chr5:16936472-16936522	GM19239	blood:	n/a
8	chr5:16936808-16936858	GM12878	blood:	n/a
9	chr5:16936369-16936419	ProgFib	skin:	n/a
10	chr5:16936466-16936516	AG09309	skin:	n/a
11	chr5:16936868-16936918	SKMC	muscle:	n/a
12	chr5:16936391-16936441	HEEpiC	esophagus:	n/a
13	chr5:16935950-16936000	NHBE	bronchial:	n/a
14	chr5:16936369-16936419	RPTEC	kidney:	n/a
15	chr5:16936868-16936918	NB4	blood:	n/a
16	chr5:16935888-16935938	ECC-1	luminal epithelium:	n/a
17	chr5:16935695-16935745	MCF10A-Er-Src	breast:	n/a
18	chr5:16936819-16936869	HNPCEpiC	eye:	n/a
19	chr5:16936466-16936516	HUVEC	blood vessel:	n/a
20	chr5:16936458-16936508	SKMC	muscle:	n/a
21	chr5:16936472-16936522	AG04450	lung:	fetal
22	chr5:16936391-16936441	HL-60	blood:	n/a
23	chr5:16936472-16936522	HUVEC	blood vessel:	n/a
24	chr5:16936500-16936550	HIPEpiC	eye:	n/a
25	chr5:16937379-16937429	PANC-1	pancreas:	n/a
26	chr5:16935950-16936000	GM06990	blood:	n/a
27	chr5:16937379-16937429	PrEC	prostate:	n/a
28	chr5:16936868-16936918	AG09319	gingival:	n/a
29	chr5:16935695-16935745	PFSK-1	brain:	n/a
30	chr5:16936458-16936508	HNPCEpiC	eye:	n/a
31	chr5:16936500-16936550	CMK	blood:	n/a
32	chr5:16936478-16936528	Jurkat	blood:	n/a
33	chr5:16936478-16936528	PrEC	prostate:	n/a
34	chr5:16936472-16936522	GM06990	blood:	n/a
35	chr5:16935695-16935745	GM12892	blood:	n/a
36	chr5:16936458-16936508	AG09309	skin:	n/a
37	chr5:16935695-16935745	AG09309	skin:	n/a
38	chr5:16936466-16936516	NH-A	brain:	n/a
39	chr5:16936369-16936419	HUVEC	blood vessel:	n/a
40	chr5:16937379-16937429	HEK293	kidney:	embryo
41	chr5:16935950-16936000	PANC-1	pancreas:	n/a
42	chr5:16935888-16935938	GM19239	blood:	n/a
43	chr5:16936470-16936520	HRE	kidney:	n/a
44	chr5:16936927-16936977	GM19239	blood:	n/a
45	chr5:16936500-16936550	NT2-D1	testis:	n/a
46	chr5:16936466-16936516	GM12892	blood:	n/a
47	chr5:16936868-16936918	NHBE	bronchial:	n/a
48	chr5:16935950-16936000	GM12878	blood:	n/a
49	chr5:16936466-16936516	IMR90	lung:	fetal
50	chr5:16936466-16936516	NHDF-neo	bronchial:	n/a

No.	Distal block	Cell Line	Cell type
1	chr1:151511929..151514676-chr5:16935884..16938127,2	MCF-7	breast:
2	chr5:16913129..16917002-chr5:16934060..16938960,5	MCF-7	breast:
3	chr19:3785424..3786388-chr5:16935883..16936687,2	Hela-S3	cervix:
4	chr5:16933857..16935914-chr5:17189210..17191344,12	MCF-7	breast:
5	chr5:16934667..16937598-chr5:17155353..17157351,2	MCF-7	breast:

Variant related genes	Relation type
MYO10	TF binding region
MYO10	CpG island
ENSG00000145555	chromatin interactions
ENSG00000143367	chromatin interactions
ENSG00000232536	chromatin interactions
ENSG00000251990	chromatin interactions
ENSG00000007264	chromatin interactions

Extended variants
information (count: 106 )
Associated
traits (count: 91 )

Variant overlapped rSNPs/rCNVs (count:106 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs568190125	chr5:16934994-16934995	Bivalent/Poised TSS Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs78660321	chr5:16935008-16935009	Bivalent/Poised TSS Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs148282948	chr5:16935009-16935010	Bivalent/Poised TSS Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs550601011	chr5:16935046-16935047	Bivalent/Poised TSS Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs185491055	chr5:16935056-16935057	Bivalent/Poised TSS Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs577211591	chr5:16935069-16935070	Bivalent/Poised TSS Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs549938997	chr5:16935092-16935093	Bivalent/Poised TSS Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs538106687	chr5:16935096-16935097	Bivalent/Poised TSS Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs141330949	chr5:16935098-16935099	Bivalent/Poised TSS Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs568833677	chr5:16935165-16935166	Bivalent/Poised TSS Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs574723625	chr5:16935173-16935174	Bivalent/Poised TSS Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs541640834	chr5:16935179-16935180	Bivalent/Poised TSS Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs73757207	chr5:16935208-16935209	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs537756665	chr5:16935323-16935324	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs199986796	chr5:16935426-16935427	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs187986486	chr5:16935469-16935470	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs192418038	chr5:16935550-16935551	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs563693007	chr5:16935556-16935557	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs537141618	chr5:16935586-16935587	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs150777896	chr5:16935615-16935616	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs544538783	chr5:16935634-16935635	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs562819157	chr5:16935683-16935684	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs559266034	chr5:16935684-16935685	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs571036013	chr5:16935696-16935697	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs548484450	chr5:16935701-16935702	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs566963326	chr5:16935711-16935712	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs527736191	chr5:16935775-16935776	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs137989934	chr5:16935793-16935794	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs570822738	chr5:16935797-16935798	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs538230106	chr5:16935804-16935805	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs371281143	chr5:16935813-16935814	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs568361469	chr5:16935831-16935832	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs374827221	chr5:16935868-16935869	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs535683579	chr5:16935875-16935876	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs369445145	chr5:16935890-16935891	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
36	rs572111428	chr5:16935900-16935901	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
37	rs545553074	chr5:16935914-16935915	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
38	rs142469364	chr5:16935923-16935924	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
39	rs575660172	chr5:16935934-16935935	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
40	rs376176506	chr5:16935950-16935951	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
41	rs535130843	chr5:16935956-16935957	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
42	rs369499918	chr5:16935961-16935962	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
43	rs373709256	chr5:16935967-16935968	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
44	rs535257065	chr5:16936006-16936007	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
45	rs530289092	chr5:16936019-16936020	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
46	rs3853120	chr5:16936025-16936026	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs560450550	chr5:16936081-16936082	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
48	rs553281092	chr5:16936121-16936122	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
49	rs552847666	chr5:16936177-16936178	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
50	rs552422557	chr5:16936207-16936208	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:91)

Disease	PMID	Source
Lung cancer	19547694	CNVD
Cri-du chat syndrome	22283845	CNVD
Disorders of sex development	21048976	CNVD
Non-small cell lung cancer	20864512	CNVD
Cancer	21183584	CNVD
Cervical squamous cell carcinoma	21590768	CNVD
Honadal dysgenesis	21048976	CNVD
Cancer	16751803	CNVD
Breast cancer	17133270	CNVD
Hepatocellular carcinoma	22174799	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Salivary gland tumor	18059337	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Kartagener syndrome	16639409	CNVD
Medulloblastoma	21979893	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	16783165	CNVD
Thyroid cancer	19087340	CNVD
Liposarcoma	21253554	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Cervical Cancer	21857958	CNVD
Cervical cancer	21062161	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Ewing''s sarcoma	17952124	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Cervical cancer	18559093	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Colorectal cancer	21645411	CNVD
Gastric cancer	22152101	CNVD
Oesophago-gastric ulcer	22152101	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Multiple myeloma	17550852	CNVD
prenatal diagnosis	22389664	CNVD
Bladder cancer	21909424	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Breast cancer	21858162	CNVD
Esophageal adenocarcinoma	19417022	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	16608533	CNVD
Anaplastic large cell lymphoma	18179710	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Intellectual disability	22102821	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Williams Syndrome	20824207	CNVD
Breast cancer	21364760	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Acute lymphoblastic leukemia	17640729	CNVD
Myoepithelioma	18604193	CNVD
Lung cancer	16740712	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Melanoma	22183965	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:454 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:16931800-16937000	Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin
2	chr5:16932600-16935400	Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
3	chr5:16932600-16937000	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
4	chr5:16932600-16937000	Active TSS	Rectal Mucosa Donor 29	rectum
5	chr5:16932600-16937200	Active TSS	HSMMtube	muscle
6	chr5:16932800-16936200	Bivalent/Poised TSS	Duodenum Smooth Muscle	Duodenum
7	chr5:16933000-16936800	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
8	chr5:16933000-16937400	Active TSS	Pancreatic Islets	Pancreatic Islet
9	chr5:16933200-16935200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
10	chr5:16933400-16935200	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
11	chr5:16933400-16935600	Bivalent/Poised TSS	Fetal Brain Female	brain
12	chr5:16933400-16937000	Active TSS	Gastric	stomach
13	chr5:16933400-16937000	Active TSS	A549	lung
14	chr5:16933600-16935200	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
15	chr5:16933600-16937000	Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
16	chr5:16933600-16937000	Active TSS	Aorta	Aorta
17	chr5:16933600-16937000	Active TSS	NHDF-Ad	bronchial
18	chr5:16933800-16935000	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
19	chr5:16933800-16935400	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
20	chr5:16933800-16935400	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
21	chr5:16933800-16936800	Active TSS	HUVEC	blood vessel
22	chr5:16933800-16936800	Active TSS	NH-A	brain
23	chr5:16933800-16937000	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
24	chr5:16933800-16937000	Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
25	chr5:16933800-16937000	Active TSS	HSMM	muscle
26	chr5:16933800-16937000	Active TSS	NHLF	lung
27	chr5:16933800-16937200	Active TSS	Ovary	ovary
28	chr5:16934000-16935000	Bivalent/Poised TSS	Rectal Smooth Muscle	rectum
29	chr5:16934000-16935200	Active TSS	Cortex derived primary cultured neurospheres	brain
30	chr5:16934000-16935200	Active TSS	Right Ventricle	heart
31	chr5:16934000-16935200	Bivalent/Poised TSS	Stomach Smooth Muscle	stomach
32	chr5:16934000-16935400	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
33	chr5:16934000-16935800	Active TSS	Fetal Muscle Trunk	muscle
34	chr5:16934000-16936200	Bivalent/Poised TSS	Colonic Mucosa	Colon
35	chr5:16934000-16936600	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
36	chr5:16934000-16936800	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
37	chr5:16934000-16937000	Active TSS	Fetal Intestine Large	intestine
38	chr5:16934000-16937000	Active TSS	Fetal Lung	lung
39	chr5:16934000-16937000	Active TSS	Lung	lung
40	chr5:16934000-16937000	Active TSS	NHEK	skin
41	chr5:16934000-16937200	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
42	chr5:16934200-16935000	Bivalent/Poised TSS	Liver	Liver
43	chr5:16934200-16935000	Flanking Active TSS	Fetal Stomach	stomach
44	chr5:16934200-16935200	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
45	chr5:16934200-16935200	Bivalent/Poised TSS	Rectal Mucosa Donor 31	rectum
46	chr5:16934200-16935400	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
47	chr5:16934200-16935400	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
48	chr5:16934200-16935400	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
49	chr5:16934200-16935400	Flanking Bivalent TSS/Enh	Adipose Nuclei	Adipose
50	chr5:16934200-16935600	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links